Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 57 - The Untold Story

BioHarvest Sciences Q1 Earnings Call Highlights

BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its direct-to-consumer VINIA products business and its contract development and manufacturing organization, or CDMO, plat

MarketBeat

Aquestive Therapeutics Q1 Earnings Call Highlights

Aquestive Therapeutics (NASDAQ:AQST) said it remains on track to resubmit its new drug application for Anaphylm, its epinephrine sublingual film for severe allergic reactions, in the third quarter of 2026, while reporting higher first-quarter revenue and a narrower net loss. On the company’s first-

MarketBeat

Aebi Schmidt Q1 Earnings Call Highlights

Aebi Schmidt (NASDAQ:AEBI) reported higher first-quarter 2026 order intake, sales and profitability, with management pointing to strong demand in Europe and the rest of the world, improving walk-in van activity in North America and a record backlog that supports its full-year outlook. The company s

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Chime Finally Turns Profitable—But Risks Remain

Chime Financial delivered its first profitable quarter as revenue growth, margin expansion, and loan growth strengthened the fintech’s future prospects.

MarketBeat

eVTOL Investing: Ditch the Taxi, Buy the Blueprint

As the eVTOL sector moves from concept to reality, the focus shifts to capital-efficient business models and the de-risked path to commercialization.

MarketBeat

AeroVironment CEO Says Drone Warfare Shift Is ‘Our Moment’ as Defense Demand Builds

AeroVironment (NASDAQ:AVAV) Chairman, President and CEO Wahid Nawabi said accelerating global security threats are reshaping defense priorities toward drones, loitering munitions and counter-unmanned aircraft systems, areas where he said the company is well positioned. Speaking at a Bank of America

MarketBeat

Resideo Technologies Q1 Earnings Call Highlights

Resideo Technologies (NYSE:REZI) reported first-quarter 2026 results above its outlook ranges and reaffirmed its full-year guidance, as executives cited solid execution across both its Products and Solutions and ADI Global Distribution businesses despite inflationary pressures and soft end markets.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Reinsurance Group of America Q1 Earnings Call Highlights

Reinsurance Group of America (NYSE:RGA) reported a strong first quarter of 2026, with management pointing to broad-based earnings strength across regions, favorable claims experience and continued capital deployment into new business opportunities. On the company’s earnings call, President and Chie

MarketBeat

RPC Q1 Earnings Call Highlights

RPC (NYSE:RES) reported higher first-quarter 2026 revenue as activity improved across most service lines despite winter storms early in the period, while profitability was pressured by job mix, fuel costs and working capital needs. President and CEO Ben M. Palmer said demand strengthened as the qua

MarketBeat

Accelerant Q1 Earnings Call Highlights

Accelerant (NYSE:ARX) reported stronger-than-expected first-quarter 2026 results, with management pointing to continued growth in its specialty insurance platform, expanding third-party insurer participation and increased use of artificial intelligence across underwriting and internal operations. C

MarketBeat

AIRO Group Q1 Earnings Call Highlights

AIRO Group (NASDAQ:AIRO) reported first-quarter 2026 revenue that declined from the prior year, while management said the results were in line with internal expectations and reaffirmed its full-year revenue growth outlook as the company shifts more of its focus toward drones. On the company’s earni

MarketBeat

Versant Q1 Earnings Call Highlights

Versant (NASDAQ:VSNT) Media Group reported a modest revenue decline in its first quarter as an independent company, while management pointed to stronger profitability, growth in digital and platform businesses, and continued investment in direct-to-consumer offerings as key priorities for 2026. Chi

MarketBeat

How Berkshire’s New York Times Bet Looks Today

Berkshire Hathaway has backed one of the world's most well-known news outlets: the New York Times. See what is to make of Berkshire's latest bet.

MarketBeat

Affirm's Google Deal Aims for Your Wallet

Affirm's landmark deal with Google seamlessly integrates its popular buy-now-pay-later financing options directly into the vast Google Pay platform.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Astec Industries Maps 2030 Growth Plan, Targets Higher Margins at Investor Day

Astec Industries (NASDAQ:ASTE) used its 2026 Investor Day to outline a five-year growth plan centered on higher recurring revenue, digital products, operational improvements and disciplined acquisitions. President and CEO Jaco van der Merwe said the Chattanooga, Tennessee-based equipment manufactur

MarketBeat

Dr. Reddy's Laboratories Q4 Earnings Call Highlights

Dr. Reddy's Laboratories (NYSE:RDY) reported what Chief Financial Officer M.V. Narasimham described as a resilient FY 2026 performance, with record annual revenue despite pressure from lower lenalidomide sales and several one-time charges during the fourth quarter. Narasimham said the company’s und

MarketBeat

Ready Capital Q1 Earnings Call Highlights

Ready Capital (NYSE:RC) said its first-quarter 2026 results reflected continued pressure from a balance sheet repositioning plan aimed at raising liquidity, reducing leverage and addressing underperforming commercial real estate assets. Chief Executive Officer Thomas Capasse said the company has ge

MarketBeat

Ralliant Q1 Earnings Call Highlights

Ralliant (NYSE:RAL) reported first-quarter 2026 results above the high end of its guidance and raised its full-year outlook, citing strength in Test & Measurement, continued demand in defense and utilities, and early benefits from productivity initiatives. President and CEO Tami Newcombe said t

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Radian Group Q1 Earnings Call Highlights

Radian Group (NYSE:RDN) said its first quarter of 2026 marked the company’s first reporting period as a “global multi-line specialty insurer” following the early February closing of its $1.7 billion acquisition of Inigo, a specialty insurance carrier operating through the Lloyd’s market. Chief Exec

MarketBeat

Redwire Q1 Earnings Call Highlights

Redwire (NYSE:RDW) reported sharply higher first-quarter 2026 revenue and record backlog, while management said the company is increasing internal research and development spending to pursue larger opportunities across space and defense markets. Chairman and CEO Peter Cannito said Redwire saw “stro

MarketBeat

D-Wave Quantum Q1 Earnings Call Highlights

D-Wave Quantum (NYSE:QBTS) reported a sharp increase in first-quarter bookings and said demand for its quantum computing systems has strengthened, even as revenue declined from a year earlier when results included a major system sale. On the company’s first-quarter 2026 earnings call, Chief Executi

MarketBeat

Qnity Electronics Q1 Earnings Call Highlights

Qnity Electronics (NYSE:Q) reported a record first quarter for fiscal 2026, with management citing strong demand tied to artificial intelligence, high-performance computing and advanced connectivity as key drivers of growth across both of its business segments. Chief Executive Officer Jon Kemp said

MarketBeat

Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar

The airline industry is heavily impacted by the Iran war, but investors may overlook more specialized maintenance and drone software companies.

MarketBeat

Oklo Stock Could Be Ready for Another Massive Run

Oklo is on track to begin commercializing some of its technology by year's end and begin generating revenue as core projects advance.

MarketBeat

Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA Conference

Assembly Biosciences (NASDAQ:ASMB) Chief Medical Officer Anuj Gaggar outlined the company’s virology strategy and upcoming clinical priorities during a Bank of America-hosted discussion, emphasizing programs in herpes simplex virus, hepatitis D and transplant-related herpes viruses. Gaggar describe

1 … 56 57 58 59

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.